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Abstract
Endogenous retroviruses (ERVs) have accumulated in vertebrate
genomes and contribute to the complexity of gene regulation. KAP1
represses ERVs during development by its recruitment to their repeti-
tive sequences through KRAB zinc-finger proteins (KZNFs), but little is
known about the regulation of ERVs in adult tissues. We observed that
KAP1 repression of HERVK14C was conserved in differentiated human
cells and performed KAP1 knockout to obtain an overview of KAP1
function. Our results show that KAP1 represses ERVs (including HERV-T
and HERV-S) and ZNF genes, both of which overlap with KAP1
binding sites and H3K9me3 in multiple cell types. Furthermore, this
pathway is functionally conserved in adult human peripheral blood
mononuclear cells. Cytosine methylation that acts on KAP1 regulated
loci is necessary to prevent an interferon response, and KAP1-depletion
leads to activation of some interferon-stimulated genes. Finally, loss of
KAP1 leads to a decrease in H3K9me3 enrichment at ERVs and ZNF
genes and an RNA-sensing response mediated through MAVS signal-
ing. These data indicate that the KAP1-KZNF pathway contributes to
genome stability and innate immune control in adult human cells.
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Introduction
Retrotransposons occupy at least half of the human genome, and
individual loci reflect the genetic conflict experienced by the host
throughout evolution [1]. Retrotransposons are divided into two
groups, those with long terminal repeats (LTR) and those without
(non-LTR). LTR retrotransposons are known as endogenous retro-
viruses (ERVs) because they are derived from exogenous retro-
viruses. ERVs constitute around 9% of the human genome [2] with
important roles in human health and disease. For example, LTRs of
the primate-specific retrovirus, MER41, function as natural poised
enhancers for a network of interferon-induced genes [3]. The co-
option of ERVs into normal processes such as development and
immune defense is the result of co-evolution of ERVs and their regu-
latory DNA sequences, which are scattered across the genome, with
their hosts over millions of years [1].
Endogenous retroviruses are subject to transcriptional repression
in adult tissues through DNMT1-dependent cytosine methylation
[4]. This serves to prevent expression of their nucleic acids and
proteins, which could potentially trigger an autoimmune response.
Treatment of cancer cells with DNA demethylating agents (based on
5-azacytidine, 5-AZA) leads to the reactivation of ERVs [5–7] and
induction of interferon-stimulated genes (ISGs). This signaling path-
way proceeds through MDA-5, MAVS, and IRF7 and is thought to
result from RNA sensing of double-stranded RNA derived from
ERVs. This mechanism may contribute to anti-tumor immunity in
patients treated with these drugs and remarkably, cancer initiating
cells pretreated with 5-AZA form fewer tumors in mice in a MAVS-
dependent manner [6]. Reactivation of ERVs in adult cells has also
been linked to autoimmune diseases such as multiple sclerosis [8].
Despite the presence and importance of ERV transcriptional regula-
tion in adult tissues, however, very little is known about the epige-
netic control pathways in operation.
In contrast, it is well known that the KAP1 and kru¨ppel-asso-
ciated box domain zinc-finger protein (KZNF) pathway initiates
epigenetic silencing at ERVs early in development [9–13]. KZNFs
(known as KZFPs in mouse) recognize DNA target sequences
mainly within repetitive DNA [14–16], and recruit KAP1 and epige-
netic modifiers including HP1, SETDB1, and DNMTs [17–19]. KAP1
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has been shown to bind to certain ERVs in human CD4+ T cells [11]
and plays a functional role in ERV regulation in human develop-
ment in neural progenitor cells [20]. KAP1 has been depleted in
several differentiated murine cell types with little effect on ERVs
[21,22]. SETDB1, in contrast, which exerts KAP1-dependent and
KAP1-independent roles in ERV silencing [13], has an established
role in repressing ERVs in somatic cells. It is augmented in certain
cancer cells where it functions in immune evasion [23], and it is
necessary for the silencing of ERVs in mouse B lymphocytes [24]
and in mouse embryonic fibroblasts [25].
The potential role and relevance of KAP1 in differentiated cells,
particularly in adult human tissues, is a fundamental and open
question, which we set out to address here by employing CRISPR/
Cas9-mediated genome editing.
Results
The human retrovirus HERVK14C is repressed by KAP1 in
undifferentiated and differentiated cells including adult PBMCs
We selected the ERV lineage HERVK14C as a tool to explore KAP1
function in differentiated cells because it has been reported to be
KAP1-regulated in undifferentiated human embryonic stem cells
(ESCs) [11]. HERVK14C is restricted to Great Apes and Old World
Monkeys (Fig 1A) and is a low copy number ERV (Fig EV1A), making
it relatively easy to study. We designed two primer sets to detect
specific HERVK14C loci (Fig 1B) and employed KAP1 depletion and
qRT–PCR to confirm that KAP1 represses these ERVs in undifferenti-
ated OCT4-expressing embryonic NTERA-2 cells (Figs 1C and EV1B).
We then focused on two differentiated cell lines, HeLa and 293T cells,
and generated KAP1 knockout clones using CRISPR/Cas9 genome
editing. We validated KAP1 knockout and complementation function-
ally using described KAP1-KZNF reporters [9,26] (Fig EV1C and D),
and we discovered that like in undifferentiated cells, KAP1 represses
HERVK14C in differentiated cell lines (Fig 1D and E). Two other
KAP1-regulated retrotransposons, L1PA4 (an L1 subfamily) and SVA
D (a SVA subfamily), in contrast, were less affected by KAP1 depletion
(Fig 1C–E). One possibility why SVAs may be harder to resurrect
could be due to their enriched cytosine methylation (Fig EV1E). Most
importantly, we found using shRNA-mediated RNAi that KAP1 is
necessary to regulate ERVs not only in cell lines but also in adult
peripheral blood mononuclear cells (PBMCs), and to a lesser extent
in CD4+ T cells (Figs 1F and EV1F–H), in which the HERVK14C 50LTR
was enriched for cytosine methylation (Fig EV1I). Overall, these
data suggest that KAP1 regulation persists in adult human cells.
A common role for KAP1 in repressing ERVs and ZNF genes
To gain insight into the role of KAP1 in differentiated cells, we
selected KAP1 knockout HeLa cell clones (from Fig 1D) for mRNA-
sequencing. Sequencing reads were mapped to the human genome
and to RepBase to assess the global expression of genes and repetitive
elements and we focused on significant changes (where differential
effects were > 2-fold with P-values < 0.05). Results reveal that KAP1
knockout induces a very specific phenotype involving over-
expression of ERVs and ZNF genes (Fig 2). ERVs (HERV-S, HERV-K,
and HERV-T, all of which are derived from exogenous retroviruses
[27,28]) were the only class of repetitive elements overexpressed in
knockout HeLa cells (Fig 2A and Dataset EV1), and as expected, these
ERV families were also bound by KAP1 according to ENCODE
data (Fig 2A and Appendix Fig S1A). These ERVs are present in
diverse primates and other mammals (Fig 2B). Of note, several retro-
transposons were downregulated in knockout cells, which might
represent indirect effects (Appendix Fig S1B). The fact that few ERVs
were reactivated may relate to the low number of active ERV tran-
scriptional units in the human compared with the mouse genome [29].
Interrogation of the transcriptome showed that KAP1 knockout
also affects several hundred cellular genes (Fig EV2A and B, Dataset
EV2). When we focused on upregulated genes (> 2-fold where
Padj < 0.05), we found that strikingly, ZNF genes, of which there
were 13 (9 of which were KZNFs) are the class of cellular genes
most significantly overexpressed (Fig 2C, with the highest 6.81×
overexpressed, Fig EV2C). All of these KZNFs are also direct KAP1-
binding targets (using ENCODE data; Fig EV2C), illustrating that
KAP1 plays a functional role in transcriptional regulation of these
genes, a notion that was previously only hypothesized [30,31].
Conserved KAP1 binding and H3K9me3 at ERVs and ZNF genes
Since KAP1 repression of ERVs and ZNF genes is a phenotype that
has also been observed in ESCs [10,11], we hypothesized that KAP1
▸Figure 1. The human retrovirus HERVK14C is repressed by KAP1 in undifferentiated and differentiated cells including adult PBMCs.A Schematic diagram showing the age of HERVK14C.
B Venn diagram showing the chromosome copies detected by the two primer sets.
C qRT–PCR expression of endogenous repeats following shRNA-mediated KAP1 depletion in NTERA-2 cells. Results were normalized to b2 microglobulin (B2M). KAP1
expression levels were verified by qRT–PCR and Western blot. A representative experiment of two experiments is shown. Two-tailed unpaired t-test P-values are as
follows: 0.002300 (HERVK14C_2; “shControl” compared to “shKAP1” at time points Day 4 and Day 6 combined).
D, E qRT–PCR expression of endogenous repeats following KAP1 knockout in HeLa (D) and 293T cells (E). Results were normalized to B2M. KAP1 expression levels were
verified by qRT–PCR and Western blot. For (E), we found that clone I (also treated with KAP1 sgRNA) retained KAP1 protein expression (E, right panel), so we only used
clones II, III, and IV to explore phenotype (E, left panel), which represented validated KAP1 knockouts. Two-tailed unpaired t-tests were done to compare the controls
(“Hela WT” in panel D or “293T WT” in panel E) against all respective KO clones (4 HeLa KO clones in panel D or 3 293T KO clones in panel E). P-values are as follows:
(D) HERVK14C_1: 0.0017, HERVK14C_2: 0.0044, SVA D VNTR: 0.0243; (E) HERVK14C_2: < 0.0001. Clones 8, 12, and 15 (from D) were selected for mRNA-sequencing. n = 4.
F qRT–PCR expression of endogenous repeats following shRNA-mediated KAP1 depletion in PBMCs (day 6 post-transduction). Results were normalized to B2M.
Unpaired t-tests: P-values: 0.0394 (L1PA4), 0.0079 (HERVK14C), 0.0009 (SVA D VNTR), 0.0033 (GAPDH), <0.001 (B2M). n = 3.
Data information: All error bars show standard deviation (SD). All numbers above bars depict fold changes compared to control cells (to one decimal place). ***P < 0.001,
**P < 0.01, and *P < 0.05.
Source data are available online for this figure.
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may bind ERVs and ZNF genes at common genomic loci in both
undifferentiated and differentiated cells. To address this question,
we determined whether any KAP1 binding sites were common
between human ESCs and differentiated cells (293T cells) using
public ChIP-seq data [11] and ENCODE data. We identified 614
common peaks (Fig EV2D and Dataset EV3). We found these loci to
be highly enriched for ERVs compared to their abundance in the
genome (Fig 2D). We determined the nearest gene to each of these
sites, and interestingly, gene ontology analysis showed that the most
common gene cluster was ZNFs (of which there were 61, including
40 KZNFs; Fig 2E), mirroring our functional data for the upregulated
genes (Fig 2C). Finally, examining the occurrence of LINE1
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Figure 2. A common role for KAP1 in repressing ERVs and ZNF genes through H3K9me3.
A Boxplots showing repeats significantly upregulated (> 2-fold where P < 0.05 using DESeq2) in knockout (N = 3) compared to wild-type (N = 3) HeLa cells based on
mRNA-sequencing data. *P = 0.0174 (HERV-S), **P = 0.0047 (HERV-K14C), ***P = 0.00013 (HERV-T LTR6B), and ***P = 1.90E-06 (HERV-T HERVS71). HERV-T and
HERV-S but not HERVK14C also reached significance when only adjusted P-values were considered, where differences are compared to the whole of RepBase. KAP1
binding (ENCODE data) is shown in Appendix Fig S1A. All numbers above bars depict fold changes compared to control cells (to one decimal place). Error bars show SD.
B Evolutionary tree showing the age of KAP1-repressed HERVs identified in (A). Here, HERV-K refers to HERVK14C. Estimated ages of stated lineages are given and
marked with a star. Myr: million years.
C The 38 upregulated genes identified (> 2-fold where Padj < 0.05) were converted to DAVID IDs and used for gene ontology analysis. Three gene clusters were
significantly enriched (P-value < 0.05, drawn on the plot as a dotted line) in the data set: zinc-finger proteins (P = 2.2 × 107), negative regulators of metabolic
processes (P = 0.0036), and angiogenesis (P = 0.011). Venn diagrams on the right show numbers of upregulated genes, ZNFs and KZNFs, and the overlap.
D The nature of conserved KAP1 binding sites between human ESCs [11] and 293Ts (ENCODE) (see Fig EV2D) is shown (left pie chart) compared to their abundance in
the genome (right pie chart).
E The 614 KAP1 common binding sites (see Fig EV2D) were interrogated for their nearest gene, and this gene list was converted to DAVID IDs and used for gene
ontology analysis. Four gene clusters were significantly enriched (P-value < 0.05, drawn on the plot as a dotted line): zinc-finger proteins (P = 1.1 × 1019),
fibronectin folding (P = 0.016), protein phosphatase (P = 0.033), and synapse (P = 0.047). Venn diagrams on the right show numbers of KAP1-bound loci, ZNFs and
KZNFs, and the overlap.
F Genomic coordinates of the common KAP1 sites identified in Fig EV3D were subjected to ChIP-seq correlation analyses using ChIP-Cor software (see Materials and
Methods). Each plot shows duplicate ChIP-seq experiments from ENCODE. See Fig EV3B for complete data.
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elements and ERVs within KAP1 binding sites in (i) human ESCs
or in (ii) 293T cells or (iii) within common sites revealed a simi-
lar pattern of distribution, except that ERV1 elements were
slightly enriched within the common sites (Fig EV3A). This
suggests that the landscape of KAP1 binding may be mainly
conserved between these cell types. We then found using
ENCODE data that common KAP1 sites correlate with the silent
chromatin mark H3K9me3, as well as with KAP1 and SETDB1 in
multiple cell types including primary adult cells (PBMCs; Figs 2F
and EV3B for the whole dataset). There was no correlation with
active histone marks (Fig EV3B).
KZNFs expressed in differentiated human cells target ERVs
We reasoned that a subset of KZNFs must be widely expressed and
at a sufficient level to recruit KAP1 to common DNA target sites. We
therefore identified the top one hundred most highly expressed
KZNFs in 293T cells using mRNA-sequencing data [32], verified
them to be expressed at the protein level (the human protein atlas
[33]), and recorded their targets where known [14,16] (Fig EV3C
and Dataset EV4). Many of these KZNFs bind to ERVs (Fig EV3C),
reflecting KAP1 binding at common loci (Fig EV3D). Of note,
ZNF274 is widely expressed (Dataset EV4) and known to bind the 30
ends of ZNF genes [30]. Interestingly, the ERV-binding KZNFs are
widely conserved among primates or mammals and recognize
ERVL or ERV1 sequences (Fig EV3E). These data show that KAP1
and KZNFs repress ERVs and ZNF genes in multiple cell types and
suggest that core KZNF-ERV interactions may be conserved
between species.
PBS-dependent de novo repression of ERVs is conserved in
primary adult cells
We next asked whether differentiated cells were equipped with high
enough levels of KAP1 and its associated epigenetic machinery to
induce de novo repression of incoming ERV sequences. KAP1/KZNFs
are known to target several retroviruses in ESCs including HERV-K
through the primer binding site (PBS) [11,12,34] as well as other
sites [21,35]. We selected the KAP1-bound and repressed HERVK14C
integrant on chromosome 15 as a model to measure de novo KAP1
repression in a reporter assay. This provirus contains a variant lysine
PBS sequence (PBSChr15), which we cloned upstream of the
HERVK14C LTR into a reporter vector (termed PBSChr15-LTR-GFP)
and tested alongside a vector containing the consensus PBS-lys1,2
sequence (PBS-LTR-GFP) or a control vector with the HERVK14C
LTR alone (LTR-GFP; Fig 3A). Using this system, we could demon-
strate that the HERVK14C chromosome 15 PBS sequence and the
consensus PBS sequence could induce KAP1-dependent reporter
repression in both undifferentiated and differentiated cells (Fig 3B
and C). Most importantly, we also detected PBS-dependent reporter
repression in PBMCs, in which we verified that repression was not
due to lack of reporter integration (Fig 3D). This suggested that a
subset of KZNFs must be expressed in multiple differentiated cell
types to recruit KAP1 to ERVs. To find out how many KZNFs are
expressed at the mRNA level in HeLa cells, 293T cells, macrophages,
and CD4+ T cells, we analyzed mRNA-sequencing data and found 77
(Fig 3E, Dataset EV5) to be conserved. We verified that several
KZNFs are also expressed at the protein level (Fig EV4).
Cytosine methylation acts on KAP1-regulated retrotransposons
and prevents innate immune activation
Endogenous retroviruses are subject to epigenetic repression in
cancer cells, and disruption of cytosine methylation with anti-cancer
5-AZA-based drugs leads to immune activation [5,6], but it is
unclear which epigenetic factors regulate 5-AZA-modulated ERVs.
We asked whether KAP1, like cytosine methylation, is involved in
controlling an intrinsic innate immune response by depleting KAP1
or treating cells with 5-AZA and measuring derepression of ERVs
and induction of ISGs. We found that depletion of KAP1 alone leads
to activation of the interferon-stimulated chemokines, CCL5 and
CXCL10 in Hela cells but not in PBMCs (Fig 4A, Appendix Fig S2A
and B). Of note, KAP1 depletion was less effective in PBMCs
(Figs 1F and EV1F). In contrast, 5-AZA treatment leads to potent
ISG induction in 293T cells, HeLa cells, and primary cells (Fig 4B,
Appendix Fig S2C). 5-AZA is thought to act through reducing DNA
methylation at retrotransposons rather than at ISGs. We verified
that these ISG promoters were not methylated (ENCODE reduced
representation bisulfite sequencing data and Ref. [6]) and found that
5-AZA treatment leads to SVA demethylation (Fig 4C). KAP1 deple-
tion has little effect on SVA DNA methylation, perhaps explaining
its only modest effect on ISGs (Fig 4C). The HERVK14C LTR, in
contrast to SVAs, retains only low levels of DNA methylation that
are little impacted by KAP1 depletion or 5-AZA (Appendix Fig S2D).
KAP1 contributes to innate immune control
Once ISGs are activated, negative regulation of the interferon
response prevents chronic immune activation [36]. Interestingly, we
found that 12 immune response genes (Appendix Table S3) were
downregulated in stable KAP1 knockout HeLa cell clones, suggesting
that they may have been first activated. Of note, negative phenotypes
would have been outselected during single-cell cloning of knockout
clones and we found that initial KAP1 depletion caused a growth
defect (Appendix Fig S2E) as described for SETDB1 depletion [25].
Therefore, we asked whether KAP1 depletion would lead to more
potent immune induction in cells where reactivation of ERV nucleic
acids and proteins is most pronounced. For this, we employed
mRNA-sequencing data from naı¨ve mouse ESCs depleted of epige-
netic factors [37]. Indeed, we found that KAP1 depletion led to acti-
vation of genes involved in innate and adaptive immunity (Fig EV5A
and B). SETDB1 depletion revealed similar results with both deple-
tions overlapping in their activation of innate immune genes as the
most significant gene cluster induced (P = 0.0017; Fig EV5C and D).
Overall, these results suggest that KAP1 contributes to the regulation
of retrotransposons and innate immune genes.
KAP1 depletion leads to a decrease in H3K9me3 at ERVs and a
MAVS-dependent innate immune response
A key question was how KAP1 is regulating ERVs and the innate
immune response in differentiated human cells. We hypothesized
that KAP1 regulates ERVs through H3K9me3 maintenance as is the
case in ESCs [10,38]. We established that H3K9me3 was enriched at
ZNF239, HERVK14C, and SVAs in both HeLa cells and 293T cells
(Fig 5A). We then used 293T cells due to their amenity to genetic
manipulation and depleted KAP1 or SETDB1 (Fig 5B, left), and
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found that either depletion led to a decrease in H3K9me3 at ZNF239
and HERVK14Cs, as well as HERVK14C reactivation (Fig 5B, right).
We next asked whether ISGs could be directly regulated
by KAP1 and H3K9me3 by employing KAP1 and H3K9me3
ChIP-seq data [11,39]. For KAP1, we had identified 6,148 bind-
ing sites (Fig EV2D), and for H3K9me3, we found 18,271
enriched sites (common to duplicate ChIPs, Fig 5C, left). We
identified 437 ISGs (genes induced 10-fold upon IFN treatment),
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Figure 4. Cytosine methylation acts on KAP1-regulated retrotransposons and prevents innate immune activation.
A qRT–PCR expression of endogenous repeats (left) and interferon stimulated genes (ISGs) (right) following shRNA-mediated KAP1 depletion in HeLa cells (day 6 post-
transduction), normalized to B2M and GAPDH, respectively. n = 2. See also Appendix Fig S2A and B.
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using the tool: http://www.interferome.org [40] and also
produced three independent sets of 437 randomly selected
genes. These genes (including 5 kb each side) were intersected
with the H3K9me3 or KAP1 peaks, which showed no significant
differences of KAP1 (present on 6% of ISGs) or silent
chromatin (H3K9me3, present on 14% of ISGs) per group
(Fig 5C, right). This suggests that KAP1 does not regulate ISGs
by directly binding to them. This is also important for under-
standing the mechanism of 5-AZA treatment of cancer since 5-
AZA can impact on H3K9me3 deposition [41].
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F Cells from (E) were untreated or transduced with shControl or shKAP1 vectors and luciferase read over time (left). Cells were also treated with control stimulants
(right). Results show the average luciferase secreted over two time points (days 5 and 6 for the left plot and days 1 and 2 for the right plot) with all error bars
showing SEM. HT-DNA: herring testis DNA. n = 2.
Data information: ***P < 0.001, **P < 0.01, and *P < 0.05.
Source data are available online for this figure.
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Finally, we asked whether the innate immune response activated
upon KAP1 depletion is caused by an RNA-sensing or a DNA-sensing
response. To address this question, we first selected THP-1 cells, in
which we detected robust induction of a luciferase-based ISG
reporter upon KAP1 depletion (Fig 5D). The reporter was IFIT-1-
promoter-driven luciferase in THP-1 cells and IFNb-promoter-driven
luciferase in 293T and HeLa cells. Here, viral FLIP (vFLIP) (from
KSHV) encoded from a lentiviral vector served as a positive control
because it constitutively activates NFjB and the immune response
[42]. We then employed CRISPR/Cas9 genome editing to disrupt the
innate adaptors STING or MAVS in THP-1 cells (Fig 5E) and
performed ISG reporter assays. MDA-5 and RIG-I RNA-sensing path-
ways are dependent on MAVS signaling [43], whereas the cGAS
DNA-sensing pathway is dependent on STING [44]. Results revealed
that ISG reporter induction observed upon KAP1 depletion is mainly
dependent on MAVS signaling, consistent with an RNA-sensing
innate immune response (Fig 5F). As expected, MAVS KO THP-1
cells were unable to mount a response to poly:IC but were competent
for DNA sensing (of herring testis DNA, HT-DNA), whereas the
reverse was true for STING KO THP1 cells (Fig 5F).
Discussion
The present work highlights the previously unknown role for KAP1
in repressing ERVs and ZNF genes in differentiated human cells
including adult cells, and in contributing to innate immune control.
KAP1 is relevant to the mode of action of anti-cancer 5-AZA-based
drugs since KAP1 and cytosine methylation repress some of the
same ERVs and suppress MAVS-dependent RNA sensing (see Fig 6
for a model). However, KAP1 knockout in differentiated cells
impacts on ERVs and cellular genes only modestly compared to the
more pronounced effects observed following KAP1 knockout in
mouse or human ESCs [11,22]. This may relate to the increased
requirement for KAP1 in early development to establish epigenetic
marks [13]. Of note, the fact that 5-AZA exerts a dramatic effect on
ISGs compared with KAP1 depletion could be due to a combination
of effects this drug has on chromatin [41].
We found that a cohort of KZNFs are widely expressed at the
mRNA and protein level in human cells and may restrict incoming
retroviruses. Intriguingly, the mouse KZFP, ZFP809 is rapidly
degraded at the protein level in mouse differentiated cells, restrict-
ing its potency mainly to ESCs [45]. An open question is whether
KZNF expression is modulated by viruses, interferon treatment, or
other stimuli as an antiviral strategy. Finally, it is possible that
KAP1 repression of common loci is dynamic and KAP1-bound ERV
regulatory sequences may have been co-opted to activate cellular
gene networks. We found here that KAP1 regulates HERV-T and
HERVK14C, both of which show evidence of co-option [27,46].
KAP1 is often enriched at regulatory hubs together with other tran-
scription factors (Appendix Fig S1).
Future work will be necessary to determine exactly which
factors act in addition to KAP1 to maintain ERV silencing in dif-
ferentiated cells. Many epigenetic regulators exert cross-talk with
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HERVs, SVAs, other
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DNMTs
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Figure 6. Model.
KAP1 regulates ERVs and ZNF genes in differentiated human cells including adult PBMCs and contributes to innate immune control. KAP1 and SETDB1 binding [30] are
detected at ERVs and ZNF genes in differentiated cells and overlap with the silent chromatin mark H3K9me3 as well as some cytosine methylation, which we detect at
HERVK14C and SVAs. KAP1 inactivation reveals that the KAP1-KZNF pathway is functionally intact and required in differentiated cells including PBMCs. KAP1 depletion leads
to a decrease in H3K9me3 at retrotransposons and to reactivation of HERVs and SVAs. These retrotransposons or potentially other endogenous RNAs produce double-
stranded RNA structures, which activate a type I interferon response through MAVS signaling. KAP1 depletion is not sufficient for global ISG induction, suggesting it exerts
partial redundancy at repressing ERVs with other epigenetic mechanisms in differentiated human cells.
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DNA methylation including SETDB1 [47], which can act indepen-
dently or in concert with KAP1 [25] and which itself has a
reported role in innate immune control in cancer cells [23].
Another key question concerns the identities of the potential
immuno-stimulatory RNAs that may derive from retrotransposons
producing secondary structure. Note, however, that to date there
is no direct link known between ERV upregulation and an ISG
response.
Hundreds of KZNFs have recently been described to target speci-
fic sequences within repetitive DNA, including ERVs [14–16]. The
relevance of such interactions, however, remains unknown. Our
work illustrates that cell lines rather than ESCs could be used to
determine the individual functions of a core set of KZNFs that are
widely expressed through their targeted gene knockout. Most inter-
estingly, KAP1 and widely expressed KZNFs in combination with
other epigenetic factors may become new drug targets for cancer
with the aim to reactivate subsets of ERVs and other retrotrans-
posons and harness their natural ability to trigger innate and adap-
tive anti-tumor immunity.
Materials and Methods
Cell culture
Human teratoma-derived NTERA-2 cells (kind gift from Peter
Andrews, University of Sheffield) were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM, Gibco) high glucose, supplemented
with 2 mM L-Glutamine, 10% fetal calf serum (FCS), and 1% Peni-
cillin/Streptomycin (P/S). They were split 1:2 or 1:3 every 3–4 days
by cell scraping. HEK293T (293T) and HeLa cells were grown in
standard DMEM + 10% FCS and P/S and split 1:4 every 2 days
using trypsin. Human primary CD4+ T cells were grown in Roswell
Park Memorial Institute medium (RPMI, Gibco) supplemented with
10% human serum and 10 U/ml of recombinant IL-2 and activated
using aCD3 and aCD28 pre-coated flasks for 72 h during which time
IL-2 was increased to 25 U/ml. Peripheral blood mononuclear cells
(PBMCs) were grown in RPMI supplemented with 20% FCS and
10 U/ml of IL-2 and activated using 3 lg/ml of Phytohemagglu-
tinin-M (PHA) for 72 h. The THP-1 ISG reporter cell line (THP-1-
IFIT-1-GLuc) was a gift from Veit Hornung. 5-azacytidine (5-AZA)
was added at 7 lM or vehicle only (DMSO).
CRISPR/Cas9 genome editing
Guide RNAs (sgRNAs, see Appendix Table S2) specific to several
different exons of KAP1 (exons 1 and 9) were designed using the
website: http://crispr.mit.edu/and cloned into the PX459 plasmid
(Addgene), which was then transfected into HeLa and HEK293 T
cells. After 24 h, the cells were subjected to puromycin selection for
24 h or until control cells had completely died. The bulk population
was then used for single-cell cloning by limiting dilution. Knockout
was assessed across a panel of clones by Western blotting using the
KAP1 antibody, MAB3662 (Millipore), and validated functionally
using KAP1-KZNF reporter assays. For knockout of STING or MAVS,
sgRNAs (listed in Appendix Table S2) were cloned into lenti-
CRISPRv2 and THP-1 cells transduced, selected with puromycin and
single cell cloned as above.
Primary cell isolation
peripheral blood mononuclear cells were isolated from a buffy coat
or from fresh blood from healthy donors using lymphoprep (Axis-
Shield). CD4+ T cells were obtained from the isolated PBMCs using
the CD4+ T cell Isolation Kit (Miltenyi Biotec) according to manu-
facturer’s instructions. The purity of the cells was verified by flow
cytometry following antibody staining. Antibodies used are shown
in Appendix Table S1.
Western blotting
1–2 × 106 cells were washed with PBS and lysed in NuPAGE LDS
sample buffer (Thermo Fisher) with 5% b-mercaptoethanol.
Samples were sonicated for 90 s at 20 Hz and heated at 95°C for
5 min. Lysates were then loaded onto handcast 10% SDS–polyacryl-
amide gels in tris/glycine/SDS buffer and mini-PROTEAN tanks
(Bio-Rad), followed by wet transfers onto polyvinylidene difluoride
(PVDF) membranes. Antibodies used for blotting the membrane are
listed below. All secondary antibodies were horseradish peroxidase-
conjugated (GE healthcare), and membranes were developed using
ECL kits (ECL, Prime or Select kits from Amersham).
shRNA lentiviral vectors and transduction
Hairpin sequences against human mRNAs were designed using the
Clonetech RNAi designer website (http://bioinfo.clontech.com/rna
idesigner/) and annealed into oligo duplexes. The duplexes were
then cloned into an shRNA vector (HIV SIREN) at BamHI-EcoRI
sites, and the products were checked by sequencing. VSV-G-pseudo-
typed lentiviral vectors were produced by co-transfecting 293T cells
in 10-cm plates with 1.5 lg of the shRNA plasmid, 1 lg p8.91, and
1 lg pMDG2 encoding VSV-G. The supernatant was harvested on
two consecutive days (from 48 h post-transfection) and used neat
or concentrated via ultracentrifugation (20,000 × g for 2 h at 4°C)
for primary cells. For immune activation assays, vectors were
pretreated with DNase to remove potential DNA from the vector
preparations. Two days post-transduction, the cells were selected
with puromycin (2.5 lg/ml) for 48 h (or until control cells had
completely died) and qRT–PCR was done 6 days post-transduction.
RNA extraction and quantification
Total RNA was extracted using an RNeasy mini kit (Qiagen) and
DNase (Ambion AM1907) treated. 500 ng of RNA was used for cDNA
production using SuperScript II Reverse Transcriptase (ThermoFisher)
and random primers following the manufacturer’s instructions.
mRNA expression levels were quantified using quantitative reverse
transcription PCR (qRT–PCR) using an ABI 7500 Real Time PCR
System (Applied Biosystems). SYBR green Fast PCR mastermix (Life
Technologies) was used. CT values for the test genes were normalized
against those of Gapdh or B2M using the DDCt method to calculate
fold change. See Appendix Table S2 for primer sequences.
DNA methylation analysis
DNA was harvested using a DNeasy Blood & Tissue Kit (Qiagen),
and 1 lg of DNA was used for bisulfite conversion using an
10 of 13 EMBO reports e45000 | 2018 ª 2018 The Authors
EMBO reports KAP1 relevance in adult human cells Christopher HC Tie et al
Published online: July 30, 2018 
EpiTect Bisulfite Kit (Qiagen) following the manufacturer’s proto-
col. 4 ll of converted DNA was then amplified through PCR using
the primer pairs described in the (Appendix Table S2). Primers
were designed using the site: http://urogene.org/methprimer/and
the PCR products were cloned using the TOPO TA-Cloning Kit
(Thermo Fisher Scientific), and the T7P primer was used to
sequence the products. DNA methylation status of the TOPO
clones was measured using the QUMA online tool (http://
quma.cdb.riken.jp) by the Riken Institute.
GFP reporter assay
The HERVK14C LTR was cloned into a PGK-GFP plasmid in place of
the PGK promoter at XhoI-BamHI sites. The consensus lysine PBS
sequence was cloned upstream of the LTR after annealing primers
into the XhoI site, while the Chromosome 15 HERVK14C-specific
lysine PBS was cloned into the backbone through a PCR strategy
into the XhoI-BamHI sites. The final products were verified via
sequencing.
Cells were plated at a concentration of 105 cells/ml in 24-well
plates. After 6 h, wells were transduced with VSV-pseudotyped
GFP vectors at increasing doses (normalized between vectors by
the number of transducing units, which were calculated by first
titering vectors on KAP1 knockout 293T cells) and fresh media
was replenished after 24 h. After a further 48 h, the cells were
fixed in 1% PFA and washed in PBS and GFP was read using
flow cytometry.
Intracellular OCT4 staining
1 × 106 cells per condition were fixed and permeabilized using
intracellular staining buffers (eBioscience, 00-5523). The cells were
then stained with OCT4 or isotype control antibodies (see Antibody
list above), washed, and analyzed by flow cytometry.
Luciferase reporter assays
Luciferase assays were conducted according to the Promega Dual
Luciferase Kit instructions. 293T cells were plated 6 h before trans-
fection at a concentration of 105 cells/ml in 24-well plates. Follow-
ing ratios defined before [9], 200 ng of KRAB ZNF plasmid DNA,
20 ng of Luciferase reporter plasmid DNA, and 2 ng of pRT-TK_Re-
nilla control plasmid were co-transfected (10:1:0.1 ratio) using
1.5 ll of Fugene 6 (Promega) and 30 ll of Opti-MEM (Gibco). Forty-
eight hours post-transfection, cells were lysed and luciferase was
measured using the Dual Luciferase assay kit (Promega, E1910) in
an opti-plate using a Glomax 96 microplate Luminometer’s
(Promega) Dual Glow program. The Renilla-encoding plasmid was
used as an internal control for transfection efficiency normalization.
The firefly to Renilla ratio was then further normalized against the
empty vector or negative control as repression readouts and
expressed in percentages where the control is set to 100%. The IFN-
b promoter-driven F-luciferase lentiviral vector plasmid [48] was a
kind gift from Jan Rehwinkel. For assays using the IFIT1-GLuc THP-
1 cells, supernatant was harvested and coelenterazine (2 lg/ml,
Prolume) was used as a substrate for luminescence readings.
Controls were herring testis DNA (HT-DNA, 1 lg/ml, Sigma) and
poly I:C (1 lg/ml Invivogen) and a vFLIP-expressing vector (kind
gift from Mary Collins). Data are presented as fold induction over
the mock-treated sample for each cell line.
mRNA-sequencing and analysis
Total RNA samples were processed using Illumina’s TruSeq
Stranded mRNA LT sample preparation kit (RS-122-2101) accord-
ing to manufacturer’s instructions with some deviations: Libraries
to be multiplexed in the same run were pooled in equimolar
quantities and calculated from Qubit and Bioanalyser fragment
analysis. Samples were sequenced on a NextSeq 500 instrument
(Illumina, San Diego, USA) using a 43 bp paired end run result-
ing in > 15 million reads per sample. Run data were demulti-
plexed and converted to fastq files using Illumina’s bcl2fastq
Conversion Software v2.16. Fastq files were then aligned to the
human genome NCBI build 37.2 using Tophat 2.014 and then
deduplicated using Picard Tools 1.79. Reads per transcript were
counted using HTSeq, and differential expression was estimated
using the BioConductor package DESeq2. P-values were adjusted
for multiple testing with the Benjamini–Hochberg false discovery
rate (FDR) procedure. Genes were considered upregulated or
downregulated where differential affects were > 2-fold and where
adjusted P-values were < 0.05. For analysis of repeats, TrimGa-
lore v0.4.0 was used to remove adaptors and trim read ends
using default parameters. Reads were mapped against the
RepBase v20.06 human library using Bowtie2v2.2.4. The
samtools v.1.19 idxstat utility was used to extract the number of
mapped reads per repeat that were inputted to DESeq2 to iden-
tify differentially expressed repeats. P-values were adjusted for
multiple testing with the Benjamini–Hochberg false discovery
rate (FDR) procedure. Gene ontology analysis was conducted
using the DAVID website: https://david-d.ncifcrf.gov/ [49,50].
Public mRNA-sequencing data were used to determine whether
KZNFs were expressed in different cell types (see data access for
accession numbers). A gene was considered to be expressed if it
had an RPKM value of > 0.5 in all replicates. The top 100
KZNFs expressed in 293T cells were determined by sorting
mRNA-sequencing data on RPKM values.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed as described [22] but using a
Bioruptor Pico for sonication (four cycles, 15 s ON, 90 s OFF) and a
H3K9me3 antibody (ab8898, Abcam). Chromatin immunoprecipita-
tion-sequencing data for human ESCs and 293T cells were down-
loaded from NCBI Gene Expression Omnibus (GEO) under accession
numbers GSE57989 (HuESC) and GSE27929 (293T). TrimGalore
v0.4.0 was used to remove adaptors and trim read ends, and reads
were mapped against the human genome (hg19 assembly) using
Bowtie2 v2.2.4. Peaks were called in each replicate using Macs2
v 2.1.1, and the bioconductor package DiffBind (https://biocond
uctor.org/packages/DiffBind) was used to construct Venn diagrams
and identify overlapping ESC and 293T peaks. Human repeat and
gene locations were downloaded from the UCSC browser (Repeat-
Masker and RefGene tables), and the repeats and genes closest to
the overlapping ESC/293T peaks were identified using bedtools
v2.17.0. Chip-sequencing correlations were analyzed using the
Chip-Cor website: http://ccg.vital-it.ch/chipseq/chip_cor.php.
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Statistical analysis
All error bars show standard deviation (SD) or standard error of the
mean (SEM), as stated. Where n ≥ 3, Student’s t-tests or other
statistical tests were used, as stated. A P-value of < 0.05 was
considered statistically significant (***P < 0.001, **P < 0.01, and
*P < 0.05).
Ethics statement
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